anti-inflammatory therapies living meta-analysis of clinical studies

demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study

	COVID-19 mild to moderate

	COVID 19 hospitalized	COVID-19 mild to moderate
anti-inflammatory therapies	Malgorzata
anti GM-CSF
mavrilimumab	MASH-COVID ...
clarithromycine	Tsiakos	Rashad ...
colchicine	GRECCO-19 Horby Scarsi Lopes MIF RECOVERY ... Salehzadeh COLCOVID Sandhu	COL-COVID ...
Colchicine plus rosuvastatin	Gaitan-Duarte ... COLSTAT
non-steroidal anti-inflammatory drugs	Jeong Drake Bruce Imam	Guzman-Esquivel
Celecoxib	Wenxin
Indomethacin		Ravichandran Ravichandran
stem cells	Lanzoni Carmenate ...